News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
June 29, 2020
Repligen Announces Agreement to Acquire Engineered Molding Technology
News
February 14, 2020
Repligen up on OPUS® and Gene Therapy Demand
Dan Stanton BioProcess International
News
October 1, 2019
Using Alternating Tangential Flow with Fed-Batch Cultures
GEN
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application
Yahoo News
News
August 12, 2019
Samsung BioLogics implants cell-culturing tech
Korea Biomed
News
August 12, 2019
Samsung BioLogics’ cell culture technique to cut production life by 30%
Pulse News
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application.
Samsung Biologics
News
May 20, 2019
OPUS focus: Repligen expands to support chromatography demand
Dan Stanton BioProcess International
Announcements
April 26, 2019
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies
Announcements
September 4, 2018
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
News
August 21, 2018
Fortune Top 100 Fastest-Growing Companies in 2018
Fortune Inc.
Announcements
June 28, 2018